Literature DB >> 12062983

FDA panel rejects common cold treatment.

Kath Senior.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 12062983     DOI： 10.1016/s1473-3099(02)00277-3

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  26 in total

1.  Enterovirus D68 Antivirals: Past, Present, and Future.

Authors:  Yanmei Hu; Rami Musharrafieh; Madeleine Zheng; Jun Wang
Journal:  ACS Infect Dis       Date:  2020-05-14       Impact factor: 5.084

Review 2.  Back to the future: Advances in development of broad-spectrum capsid-binding inhibitors of enteroviruses.

Authors:  Anna Egorova; Sean Ekins; Michaela Schmidtke; Vadim Makarov
Journal:  Eur J Med Chem       Date:  2019-06-11       Impact factor: 6.514

3.  A Novel Capsid Binding Inhibitor Displays Potent Antiviral Activity against Enterovirus D68.

Authors:  Chunlong Ma; Yanmei Hu; Jiantao Zhang; Rami Musharrafieh; Jun Wang
Journal:  ACS Infect Dis       Date:  2019-09-18       Impact factor: 5.084

4.  Neonate with coxsackie B1 infection, cardiomyopathy and arrhythmias.

Authors:  Jimmy C Lu; Kelly W Koay; Christian B Ramers; Angelo S Milazzo
Journal:  J Natl Med Assoc       Date:  2005-07       Impact factor: 1.798

Review 5.  Human rhinoviruses.

Authors:  Samantha E Jacobs; Daryl M Lamson; Kirsten St George; Thomas J Walsh
Journal:  Clin Microbiol Rev       Date:  2013-01       Impact factor: 26.132

6.  Anti-enteroviral triple combination of viral replication inhibitors: activity against coxsackievirus B1 neuroinfection in mice.

Authors:  Adelina Stoyanova; Ivanka Nikolova; Gerhard Pürstinger; Georgi Dobrikov; Vladimir Dimitrov; Stefan Philipov; Angel S Galabov
Journal:  Antivir Chem Chemother       Date:  2016-11-04

7.  An Orally Available 3-Ethoxybenzisoxazole Capsid Binder with Clinical Activity against Human Rhinovirus.

Authors:  Susanne C Feil; Stephanie Hamilton; Guy Y Krippner; Bo Lin; Angela Luttick; Darryl B McConnell; Roland Nearn; Michael W Parker; Jane Ryan; Pauline C Stanislawski; Simon P Tucker; Keith G Watson; Craig J Morton
Journal:  ACS Med Chem Lett       Date:  2012-02-13       Impact factor: 4.345

8.  Exploration of the anti-enterovirus activity of a series of pleconaril/pirodavir-like compounds.

Authors:  Angela Bernard; Céline Lacroix; Maria G Cabiddu; Johan Neyts; Pieter Leyssen; Raffaello Pompei
Journal:  Antivir Chem Chemother       Date:  2015-06-11

Review 9.  How I treat respiratory viral infections in the setting of intensive chemotherapy or hematopoietic cell transplantation.

Authors:  Alpana Waghmare; Janet A Englund; Michael Boeckh
Journal:  Blood       Date:  2016-03-11       Impact factor: 22.113

Review 10.  The role of viral infections in exacerbations of chronic obstructive pulmonary disease and asthma.

Authors:  Richard Hewitt; Hugo Farne; Andrew Ritchie; Emma Luke; Sebastian L Johnston; Patrick Mallia
Journal:  Ther Adv Respir Dis       Date:  2015-11-26       Impact factor: 4.031
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.